Marcie Schwartz
Psychiatric/Mental Health · Mason, MINPI 1730146663
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 208 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,243 and has fallen 54.6% since, to $1,019 in 2025. Among psychiatric/mental health clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 208 payments — averaging $25.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$766
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$700
- Alkermes, Inc.$675
- Otsuka America Pharmaceutical, Inc.$429
- Axsome Therapeutics, Inc.$423
- Teva Pharmaceuticals USA, Inc.$418
- plus $2K from 17 others
What the payments were for
- Food & beverage$5,367100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 27 | $766 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $700 |
| Alkermes, Inc. | 23 | $675 |
| Otsuka America Pharmaceutical, Inc. | 20 | $429 |
| Axsome Therapeutics, Inc. | 12 | $423 |
| Teva Pharmaceuticals USA, Inc. | 13 | $418 |
| Johnson & Johnson | 21 | $416 |
| AbbVie | 15 | $309 |
| Corium, LLC | 10 | $230 |
| Supernus Pharmaceuticals, Inc. | 6 | $198 |
| Ironshore Pharmaceuticals Inc. | 10 | $194 |
| Lundbeck LLC | 7 | $148 |
| E.r. Squibb & Sons, L.L.C. | 1 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $85 |
| Novo Nordisk | 4 | $82 |
| Biogen | 3 | $58 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Sunovion Pharmaceuticals Inc. | 1 | $22 |
| Exact Sciences | 1 | $19 |
| Bayer | 1 | $14 |
| AstraZeneca | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| OWP Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$242
- COBENFY$120
- Austedo XR$113
- QELBREE$112
- REXULTI$108
How this compares
$5,375 in reported general payments places this provider in the 90th percentile of 638 psychiatric/mental health providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trazodone Hcl | 28 | $270 |
| Quetiapine Fumarate | 11 | $147 |
| Hydroxyzine Pamoate | 14 | $139 |
| Sertraline Hcl | 13 | $136 |
| Clonazepam | 12 | $130 |
| Fluoxetine Hcl | 17 | $121 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Mason
- Duren GutierrezSouthfield$207K
- Tamlynn EvansTraverse City$78K
- Shiba NixonClarkston$60K
- Amy AmesClinton Township$43K
- Cody ShinavierClarkston$41K
- Oksana LidkeBattle Creek$30K
- Jennifer Wims-MaddenPontiac$28K
- Jessica ShantzWarren$21K
- Gladys KimeliSaginaw$17K
- Cynthia MaiSaginaw$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.